{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:06:37Z","timestamp":1793149597407,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["UM1HG007292"],"award-info":[{"award-number":["UM1HG007292"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA132829"],"award-info":[{"award-number":["R01CA132829"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lynch syndrome (LS) is the most common inherited cause of colorectal and endometrial cancers. Identifying individuals at risk for LS without personal cancer history requires detailed collection and assessment of family health history. However, barriers exist to family health history collection, especially in historically underserved populations. To improve LS risk assessment in historically underserved populations, we adapted the provider-facing PREdiction Model for gene Mutations (PREMM<jats:sub>5<\/jats:sub>\u2122 model), a validated LS risk assessment model, into a patient-facing electronic application through an iterative development process involving expert and patient stakeholders. We report on preliminary findings based on the first 500 individuals exposed to the adapted application in a primary care population enriched for low-literacy and low-resource patients. Major adaptations to the PREMM<jats:sub>5<\/jats:sub>\u2122 provider module included reduction in reading level, addition of interactive literacy aids, incorporation of family history assessment for both maternal and paternal sides of the family, and inclusion of questions about individual relatives or small groups of relatives to reduce cognitive burden. In the first 500 individuals, 90% completed the PREMM<jats:sub>5<\/jats:sub>\u2122 independently; of those, 94% did so in 5\u00a0min or less (ranged from 0.2 to 48.8\u00a0min). The patient-facing application was able to accurately classify 84% of patients as having clinically significant or not clinically significant LS risk. Our preliminary results suggest that in this diverse study population, most participants were able to rapidly, accurately, and independently complete an interactive application collecting family health history assessment that accurately assessed for Lynch syndrome risk.<\/jats:p>","DOI":"10.1007\/s10689-021-00243-3","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T02:02:36Z","timestamp":1616464956000},"page":"167-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5\u2122) for lynch syndrome risk assessment in a diverse population"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1097-9171","authenticated-orcid":false,"given":"Kathleen F.","family":"Mittendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinedu","family":"Ukaegbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian J.","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nangel M.","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tia L.","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna J.","family":"Eubanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmit","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather Spencer","family":"Feigelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine P.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Ezzell","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Okuyama","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamilyn M.","family":"Zepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Syngal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Wilfond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina A. B.","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"issue":"21","key":"243_CR1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1056\/NEJM199805213382101","volume":"338","author":"LA Aaltonen","year":"1998","unstructured":"Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, Chadwick RB, Kaariainen H, Eskelinen M, Jarvinen H, Mecklin JP, de la Chapelle A (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338(21):1481\u20131487. https:\/\/doi.org\/10.1056\/NEJM199805213382101","journal-title":"N Engl J Med"},{"issue":"35","key":"243_CR2","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1200\/JCO.2008.17.5950","volume":"26","author":"H Hampel","year":"2008","unstructured":"Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A (2008) Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26(35):5783\u20135788. https:\/\/doi.org\/10.1200\/JCO.2008.17.5950","journal-title":"J Clin Oncol"},{"issue":"15","key":"243_CR3","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/jama.2012.13088","volume":"308","author":"L Moreira","year":"2012","unstructured":"Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, Haile R, Thibodeau SN, Gunawardena S, Jenkins MA, Buchanan DD, Potter JD, Baron JA, Ahnen DJ, Moreno V, Andreu M, Ponz de Leon M, Rustgi AK, Castells A, Consortium E (2012) Identification of Lynch syndrome among patients with colorectal cancer. JAMA 308(15):1555\u20131565. https:\/\/doi.org\/10.1001\/jama.2012.13088","journal-title":"JAMA"},{"issue":"3","key":"243_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10689-004-3906-5","volume":"4","author":"HF Vasen","year":"2005","unstructured":"Vasen HF (2005) Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]. Fam Cancer 4(3):219\u2013225. https:\/\/doi.org\/10.1007\/s10689-004-3906-5","journal-title":"Fam Cancer"},{"issue":"10","key":"243_CR5","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","volume":"35","author":"MB Yurgelun","year":"2017","unstructured":"Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL, Ukaegbu CI, Brais LK, McNamara PG, Mayer RJ, Schrag D, Meyerhardt JA, Ng K, Kidd J, Singh N, Hartman AR, Wenstrup RJ, Syngal S (2017) Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol 35(10):1086\u20131095. https:\/\/doi.org\/10.1200\/JCO.2016.71.0012","journal-title":"J Clin Oncol"},{"key":"243_CR6","unstructured":"National Comprehensive Cancer Network (NCCN) (2019) Clinical practice guidelines in oncology: genetic\/familial high-risk assessment: colorectal V1.2019."},{"issue":"3","key":"243_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","volume":"66","author":"P Moller","year":"2017","unstructured":"Moller P, Seppala T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rodland EA, Tharmaratnam K, Cappel WHDVTN, Hill J, Wijnen J, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Frayling IM, Plazzer JP, Pylvanainen K, Sampson JR, Capella G, Mecklin JP, Moslein G, Mallorca G (2017) Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut 66(3):464\u2013472. https:\/\/doi.org\/10.1136\/gutjnl-2015-309675","journal-title":"Gut"},{"key":"243_CR8","unstructured":"Casey N (2017) Lynch Syndrome is a common hereditary condition that can cause ovarian cancer\u2014So why isn\u2019t anybody talking about it? Health & Fitness"},{"issue":"1","key":"243_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-013-2669-9","volume":"141","author":"P Pujol","year":"2013","unstructured":"Pujol P, Lyonnet DS, Frebourg T, Blin J, Picot MC, Lasset C, Dugast C, Berthet P, de Paillerets BB, Sobol H, Grandjouan S, Soubrier F, Buecher B, Guimbaud R, Lidereau R, Jonveaux P, Houdayer C, Giraud S, Olschwang S, Nogue E, Galibert V, Bara C, Nowak F, Khayat D, Nogues C (2013) Lack of referral for genetic counseling and testing in BRCA1\/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests. Breast Cancer Res Treat 141(1):135\u2013144. https:\/\/doi.org\/10.1007\/s10549-013-2669-9","journal-title":"Breast Cancer Res Treat"},{"key":"243_CR10","unstructured":"Institute. NC (2016) Cancer moonshot blue ribbon panel report"},{"issue":"1","key":"243_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12687-010-0030-0","volume":"2","author":"I Nippert","year":"2011","unstructured":"Nippert I, Harris HJ, Julian-Reynier C, Kristoffersson U, Ten Kate LP, Anionwu E, Benjamin C, Challen K, Schmidtke J, Nippert RP, Harris R (2011) Confidence of primary care physicians in their ability to carry out basic medical genetic tasks-a European survey in five countries-Part 1. J Community Genet 2(1):1\u201311. https:\/\/doi.org\/10.1007\/s12687-010-0030-0","journal-title":"J Community Genet"},{"issue":"4","key":"243_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/13814780903447572","volume":"15","author":"AW Plat","year":"2009","unstructured":"Plat AW, Kroon AA, Van Schayck CP, De Leeuw PW, Stoffers HE (2009) Obtaining the family history for common, multifactorial diseases by family physicians. A descriptive systematic review. Eur J Gen Pract 15(4):231\u2013242. https:\/\/doi.org\/10.3109\/13814780903447572","journal-title":"Eur J Gen Pract"},{"key":"243_CR13","first-page":"970","volume":"2018","author":"M Sin","year":"2018","unstructured":"Sin M, McGuinness JE, Trivedi MS, Vanegas A, Silverman TB, Crew KD, Kukafka R (2018) Automatic genetic risk assessment calculation using breast cancer family history data from the ehr compared to self-report. AMIA Annu Symp Proc 2018:970\u2013978","journal-title":"AMIA Annu Symp Proc"},{"key":"243_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2296-11-45","volume":"11","author":"BS Flynn","year":"2010","unstructured":"Flynn BS, Wood ME, Ashikaga T, Stockdale A, Dana GS, Naud S (2010) Primary care physicians\u2019 use of family history for cancer risk assessment. BMC Fam Pract 11:45. https:\/\/doi.org\/10.1186\/1471-2296-11-45","journal-title":"BMC Fam Pract"},{"issue":"3","key":"243_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.amepre.2004.05.003","volume":"27","author":"HJ Murff","year":"2004","unstructured":"Murff HJ, Byrne D, Syngal S (2004) Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med 27(3):239\u2013245. https:\/\/doi.org\/10.1016\/j.amepre.2004.05.003","journal-title":"Am J Prev Med"},{"issue":"8","key":"243_CR16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1200\/JCO.2013.51.4661","volume":"32","author":"ME Wood","year":"2014","unstructured":"Wood ME, Kadlubek P, Pham TH, Wollins DS, Lu KH, Weitzel JN, Neuss MN, Hughes KS (2014) Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. J Clin Oncol 32(8):824\u2013829. https:\/\/doi.org\/10.1200\/JCO.2013.51.4661","journal-title":"J Clin Oncol"},{"issue":"5","key":"243_CR17","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/AOG.0b013e3181da08d7","volume":"115","author":"LA Meyer","year":"2010","unstructured":"Meyer LA, Anderson ME, Lacour RA, Suri A, Daniels MS, Urbauer DL, Nogueras-Gonzalez GM, Schmeler KM, Gershenson DM, Lu KH (2010) Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol 115(5):945\u2013952. https:\/\/doi.org\/10.1097\/AOG.0b013e3181da08d7","journal-title":"Obstet Gynecol"},{"issue":"13","key":"243_CR18","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1002\/cncr.30621","volume":"123","author":"D Cragun","year":"2017","unstructured":"Cragun D, Weidner A, Lewis C, Bonner D, Kim J, Vadaparampil ST, Pal T (2017) Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors. Cancer 123(13):2497\u20132505. https:\/\/doi.org\/10.1002\/cncr.30621","journal-title":"Cancer"},{"issue":"6","key":"243_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/ejhg.2014.180","volume":"23","author":"T Delikurt","year":"2015","unstructured":"Delikurt T, Williamson GR, Anastasiadou V, Skirton H (2015) A systematic review of factors that act as barriers to patient referral to genetic services. Eur J Human Genet: EJHG 23(6):739\u2013745. https:\/\/doi.org\/10.1038\/ejhg.2014.180","journal-title":"Eur J Human Genet: EJHG"},{"issue":"22","key":"243_CR20","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1200\/jco.2015.66.0019","volume":"34","author":"AM McCarthy","year":"2016","unstructured":"McCarthy AM, Bristol M, Domchek SM, Groeneveld PW, Kim Y, Motanya UN, Shea JA, Armstrong K (2016) Health care segregation, physician recommendation, and racial disparities in BRCA1\/2 testing among women with breast cancer. J Clin Oncol 34(22):2610\u20132618. https:\/\/doi.org\/10.1200\/jco.2015.66.0019","journal-title":"J Clin Oncol"},{"issue":"6","key":"243_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/GIM.0b013e3181770184","volume":"10","author":"AE Shields","year":"2008","unstructured":"Shields AE, Burke W, Levy DE (2008) Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med 10(6):404\u2013414. https:\/\/doi.org\/10.1097\/GIM.0b013e3181770184","journal-title":"Genet Med"},{"issue":"3","key":"243_CR22","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/cam4.1864","volume":"8","author":"MH Stamp","year":"2019","unstructured":"Stamp MH, Gordon OK, Childers CP, Childers KK (2019) Painting a portrait: analysis of national health survey data for cancer genetic counseling. Cancer Med 8(3):1306\u20131314. https:\/\/doi.org\/10.1002\/cam4.1864","journal-title":"Cancer Med"},{"issue":"12","key":"243_CR23","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1007\/s11606-013-2442-0","volume":"28","author":"MF Murray","year":"2013","unstructured":"Murray MF, Giovanni MA, Klinger E, George E, Marinacci L, Getty G, Brawarsky P, Rocha B, Orav EJ, Bates DW, Haas JS (2013) Comparing electronic health record portals to obtain patient-entered family health history in primary care. J Gen Intern Med 28(12):1558\u20131564. https:\/\/doi.org\/10.1007\/s11606-013-2442-0","journal-title":"J Gen Intern Med"},{"key":"243_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2296-15-31","volume":"15","author":"RR Wu","year":"2014","unstructured":"Wu RR, Himmel TL, Buchanan AH, Powell KP, Hauser ER, Ginsburg GS, Henrich VC, Orlando LA (2014) Quality of family history collection with use of a patient facing family history assessment tool. BMC Fam Pract 15:31. https:\/\/doi.org\/10.1186\/1471-2296-15-31","journal-title":"BMC Fam Pract"},{"issue":"1","key":"243_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/14737159.2017.1267567","volume":"17","author":"D Cragun","year":"2017","unstructured":"Cragun D, Kinney AY, Pal T (2017) Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing. Expert Rev Mol Diagn 17(1):57\u201370. https:\/\/doi.org\/10.1080\/14737159.2017.1267567","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"243_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41436-018-0028-2","volume":"21","author":"RF Green","year":"2019","unstructured":"Green RF, Ari M, Kolor K, Dotson WD, Bowen S, Habarta N, Rodriguez JL, Richardson LC, Khoury MJ (2019) Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework. Genet Med 21(1):28\u201337. https:\/\/doi.org\/10.1038\/s41436-018-0028-2","journal-title":"Genet Med"},{"issue":"4","key":"243_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12687-017-0317-5","volume":"8","author":"SS Mathew","year":"2017","unstructured":"Mathew SS, Barwell J, Khan N, Lynch E, Parker M, Qureshi N (2017) Inclusion of diverse populations in genomic research and health services: Genomix workshop report. J Community Genet 8(4):267\u2013273. https:\/\/doi.org\/10.1007\/s12687-017-0317-5","journal-title":"J Community Genet"},{"issue":"8","key":"243_CR28","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1377\/hlthaff.2015.1476","volume":"35","author":"CE Smith","year":"2016","unstructured":"Smith CE, Fullerton SM, Dookeran KA, Hampel H, Tin A, Maruthur NM, Schisler JC, Henderson JA, Tucker KL, Ordovas JM (2016) using genetic technologies to reduce, rather than widen. Health Disparities Health Aff (Millwood) 35(8):1367\u20131373. https:\/\/doi.org\/10.1377\/hlthaff.2015.1476","journal-title":"Health Disparities Health Aff (Millwood)"},{"issue":"3","key":"243_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ajhg.2018.08.007","volume":"103","author":"LM Amendola","year":"2018","unstructured":"Amendola LM, Berg JS, Horowitz CR, Angelo F, Bensen JT, Biesecker BB, Biesecker LG, Cooper GM, East K, Filipski K, Fullerton SM, Gelb BD, Goddard KAB, Hailu B, Hart R, Hassmiller-Lich K, Joseph G, Kenny EE, Koenig BA, Knight S, Kwok PY, Lewis KL, McGuire AL, Norton ME, Ou J, Parsons DW, Powell BC, Risch N, Robinson M, Rini C, Scollon S, Slavotinek AM, Veenstra DL, Wasserstein MP, Wilfond BS, Hindorff LA, Consortium C, Plon SE, Jarvik GP (2018) The clinical sequencing evidence-generating research consortium: integrating genomic sequencing in diverse and medically underserved populations. Am J Hum Genet 103(3):319\u2013327. https:\/\/doi.org\/10.1016\/j.ajhg.2018.08.007","journal-title":"Am J Hum Genet"},{"issue":"19","key":"243_CR30","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1200\/JCO.2016.69.6120","volume":"35","author":"F Kastrinos","year":"2017","unstructured":"Kastrinos F, Uno H, Ukaegbu C, Alvero C, McFarland A, Yurgelun MB, Kulke MH, Schrag D, Meyerhardt JA, Fuchs CS, Mayer RJ, Ng K, Steyerberg EW, Syngal S (2017) Development and validation of the PREMM5 model for comprehensive risk assessment of lynch syndrome. J Clin Oncol 35(19):2165\u20132172. https:\/\/doi.org\/10.1200\/JCO.2016.69.6120","journal-title":"J Clin Oncol"},{"issue":"1","key":"243_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cgh.2017.06.038","volume":"16","author":"DG Luba","year":"2018","unstructured":"Luba DG, DiSario JA, Rock C, Saraiya D, Moyes K, Brown K, Rushton K, Ogara MM, Raphael M, Zimmerman D, Garrido K, Silguero E, Nelson J, Yurgelun MB, Kastrinos F, Wenstrup RJ, Syngal S (2018) Community practice implementation of a self-administered version of PREMM1,2,6 to assess risk for lynch syndrome. Clin Gastroenterol Hepatol 16(1):49\u201358. https:\/\/doi.org\/10.1016\/j.cgh.2017.06.038","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"243_CR32","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41436-020-0763-z","volume":"22","author":"SA Kraft","year":"2020","unstructured":"Kraft SA, McMullen C, Lindberg NM, Bui D, Shipman K, Anderson K, Joseph G, Duenas DM, Porter KM, Kauffman TL, Koomas A, Ransom CL, Jackson P, Goddard KAB, Wilfond BS, Lee SS (2020) Integrating stakeholder feedback in translational genomics research: an ethnographic analysis of a study protocol\u2019s evolution. Genet Med 22(6):1094\u20131101. https:\/\/doi.org\/10.1038\/s41436-020-0763-z","journal-title":"Genet Med"},{"issue":"4","key":"243_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/GIM.0b013e3181d4bc3a","volume":"12","author":"C Bellcross","year":"2010","unstructured":"Bellcross C (2010) Further development and evaluation of a breast\/ovarian cancer genetics referral screening tool. Genet Med 12(4):240. https:\/\/doi.org\/10.1097\/GIM.0b013e3181d4bc3a","journal-title":"Genet Med"},{"issue":"1","key":"243_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41436-018-0020-x","volume":"21","author":"C Bellcross","year":"2019","unstructured":"Bellcross C, Hermstad A, Tallo C, Stanislaw C (2019) Validation of version 3.0 of the breast cancer genetics referral screening tool (B-RST). Genet Med 21(1):181\u2013184. https:\/\/doi.org\/10.1038\/s41436-018-0020-x","journal-title":"Genet Med"},{"issue":"11","key":"243_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/GIM.0b013e3181b9b04a","volume":"11","author":"CA Bellcross","year":"2009","unstructured":"Bellcross CA, Lemke AA, Pape LS, Tess AL, Meisner LT (2009) Evaluation of a breast\/ovarian cancer genetics referral screening tool in a mammography population. Genet Med 11(11):783\u2013789. https:\/\/doi.org\/10.1097\/GIM.0b013e3181b9b04a","journal-title":"Genet Med"},{"issue":"8","key":"243_CR36","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1177\/0272989X15581800","volume":"35","author":"CD McNaughton","year":"2015","unstructured":"McNaughton CD, Cavanaugh KL, Kripalani S, Rothman RL, Wallston KA (2015) Validation of a short, 3-item version of the subjective numeracy scale. Med Decis Mak 35(8):932\u2013936. https:\/\/doi.org\/10.1177\/0272989X15581800","journal-title":"Med Decis Mak"},{"issue":"4","key":"243_CR37","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.3747\/co.25.4042","volume":"25","author":"JE Cleophat","year":"2018","unstructured":"Cleophat JE, Nabi H, Pelletier S, Bouchard K, Dorval M (2018) What characterizes cancer family history collection tools? A critical literature review. Curr Oncol (Toronto, Ont) 25(4):e335\u2013e350. https:\/\/doi.org\/10.3747\/co.25.4042","journal-title":"Curr Oncol (Toronto, Ont)"},{"issue":"7","key":"243_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/GIM.0b013e3181a7e8e0","volume":"11","author":"N Qureshi","year":"2009","unstructured":"Qureshi N, Carroll JC, Wilson B, Santaguida P, Allanson J, Brouwers M, Raina P (2009) The current state of cancer family history collection tools in primary care: a systematic review. Genet Med 11(7):495\u2013506. https:\/\/doi.org\/10.1097\/GIM.0b013e3181a7e8e0","journal-title":"Genet Med"},{"key":"243_CR39","first-page":"1","volume":"159","author":"N Qureshi","year":"2007","unstructured":"Qureshi N, Wilson B, Santaguida P, Carroll J, Allanson J, Culebro CR, Brouwers M, Raina P (2007) Collection and use of cancer family history in primary care. Evid Rep Technol Assess (Full Rep) 159:1\u201384","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"243_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.publhealth.012809.103621","volume":"31","author":"R Valdez","year":"2010","unstructured":"Valdez R, Yoon PW, Qureshi N, Green RF, Khoury MJ (2010) Family history in public health practice: a genomic tool for disease prevention and health promotion. Annu Rev Public Health 31:69\u201387. https:\/\/doi.org\/10.1146\/annurev.publhealth.012809.103621","journal-title":"Annu Rev Public Health"},{"key":"243_CR41","unstructured":"Center for Disease Control's (CDC) Office of public health genomics (OPHG). ACCE model process for evaluating genetic tests. https:\/\/www.cdc.gov\/genomics\/gtesting\/acce\/index.htm."},{"key":"243_CR42","volume-title":"Practice statistics for medical research","author":"G Ad","year":"1991","unstructured":"Ad G (1991) Practice statistics for medical research. Chapman and Hall, London"},{"issue":"1","key":"243_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2307\/2532051","volume":"45","author":"IKL Lawrence","year":"1989","unstructured":"Lawrence IKL (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45(1):255\u2013268. https:\/\/doi.org\/10.2307\/2532051","journal-title":"Biometrics"},{"issue":"2","key":"243_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10897-018-0235-7","volume":"27","author":"BM Welch","year":"2018","unstructured":"Welch BM, Wiley K, Pflieger L, Achiangia R, Baker K, Hughes-Halbert C, Morrison H, Schiffman J, Doerr M (2018) Review and comparison of electronic patient-facing family health history tools. J Genet Couns 27(2):381\u2013391. https:\/\/doi.org\/10.1007\/s10897-018-0235-7","journal-title":"J Genet Couns"},{"issue":"679","key":"243_CR45","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.3399\/bjgp18X700265","volume":"69","author":"F Laforest","year":"2019","unstructured":"Laforest F, Kirkegaard P, Mann B, Edwards A (2019) Genetic cancer risk assessment in general practice: systematic review of tools available, clinician attitudes, and patient outcomes. Br J Gen Pract 69(679):e97\u2013e105. https:\/\/doi.org\/10.3399\/bjgp18X700265","journal-title":"Br J Gen Pract"},{"issue":"2","key":"243_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/13814788.2013.840825","volume":"20","author":"CL de Hoog","year":"2014","unstructured":"de Hoog CL, Portegijs PJ, Stoffers HE (2014) Family history tools for primary care are not ready yet to be implemented. A systematic review. Eur J Gen Pract 20(2):125\u2013133. https:\/\/doi.org\/10.3109\/13814788.2013.840825","journal-title":"Eur J Gen Pract"},{"key":"243_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13053-017-0083-8","volume":"16","author":"SA Gardner","year":"2018","unstructured":"Gardner SA, Weymouth KS, Kelly WS, Bogdanova E, Chen W, Lupu D, Suhl J, Zeng Q, Geigenm\u00fcller U, Boles D, Okamoto PM, McDowell G, Hayden MA, Nagan N (2018) Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory. Hered Cancer Clin Pract 16:1\u20131. https:\/\/doi.org\/10.1186\/s13053-017-0083-8","journal-title":"Hered Cancer Clin Pract"},{"issue":"11","key":"243_CR48","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/gim.2014.40","volume":"16","author":"H LaDuca","year":"2014","unstructured":"LaDuca H, Stuenkel AJ, Dolinsky JS, Keiles S, Tandy S, Pesaran T, Chen E, Gau CL, Palmaer E, Shoaepour K, Shah D, Speare V, Gandomi S, Chao E (2014) Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med 16(11):830\u2013837. https:\/\/doi.org\/10.1038\/gim.2014.40","journal-title":"Genet Med"},{"key":"243_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/jpm8010002","author":"R Fossey","year":"2018","unstructured":"Fossey R, Kochan D, Winkler E, Pacyna JE, Olson J, Thibodeau S, Connolly JJ, Harr M, Behr MA, Prows CA, Cobb B, Myers MF, Leslie ND, Namjou-Khales B, Milo Rasouly H, Wynn J, Fedotov A, Chung WK, Gharavi A, Williams JL, Pais L, Holm I, Aufox S, Smith ME, Scrol A, Leppig K, Jarvik GP, Wiesner GL, Li R, Stroud M, Smoller JW, Sharp RR, Kullo IJ (2018) Ethical considerations related to return of results from genomic medicine projects: the emerge network (Phase III) experience. J Pers Med. https:\/\/doi.org\/10.3390\/jpm8010002","journal-title":"J Pers Med"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00243-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-021-00243-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00243-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:56:23Z","timestamp":1648583783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-021-00243-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1007\/s10689-021-00243-3","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"30 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"PREMM\u00ae and all associated logos are trademarks\u2122 or registered\u00ae trademarks of Dana Farber Cancer Institute, Inc. Dr. Syngal has served as a consultant for Myriad Genetics and DC Health Technologies, and has rights to an inventor portion of the licensing revenue from PREMM\u00ae<sub>5<\/sub>.All other authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The KPNW Institutional Review Board (IRB) approved this study and all collaborating IRBs ceded to KPNW except Dana Farber Cancer Institute and Columbia University, who approved the study separately.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All study participants provided informed consent prior to study enrollment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}